Jane Street
DCOY

Jane Street’s Decoy Therapeutics DCOY Stock Holding History

Jane Street’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– -$4K – 10770
2022
Q1 		– Hold
0
– – – 10142
2021
Q3 		– Sell
-1
Closed -$22K – 10649
2021
Q2 		$22K Buy
+1
New +$44.5K ﹤0.01% 9633
2019
Q3 		– Hold
0
– -$7K – 5687
2019
Q2 		– Hold
0
– – – 5049
2019
Q1 		– Hold
0
– -$3K – 5581
2018
Q4 		– Hold
0
– – – 4841

Other funds holding DCOY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $394M AUM 44.75% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Jane Street's DCOY Position: Q2 2022 in Review

Jane Street held its Decoy Therapeutics (DCOY) position steady in Q2 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #10770.

Jane Street first reported a position in DCOY in Q2 2021 and has held it in 1 quarter since. The position peaked at $22K in Q2 2021. 19 funds tracked by Wall St. Rank hold DCOY as of Q2 2022.

  • Jane Street held 0 shares of Decoy Therapeutics worth $0 as of Q2 2022.
  • Jane Street left its Decoy Therapeutics share count unchanged in Q2 2022.
  • Decoy Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2022, its #10770 holding.
  • Jane Street first reported a position in Decoy Therapeutics in Q2 2021 and has held it in 1 quarter since.
  • Jane Street's Decoy Therapeutics position peaked at $22K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q2 2022.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.